Pfizer (PFIZER.NS) Akcija Цена
Pfizer Цена
Prihod je rastao 7,0 % godišnje u poslednjih 19 godina na 25,20 Млрд INR. Zarada po akciji rasla je 10,6 % godišnje u poslednjih 19 godina. neto marža kompanije Pfizer sada iznosi 28,7 %, porasla sa 23,5 % pre nekoliko godina. Pfizer trenutno nudi dividendni prinos od oko 3,45 %. Odnos isplate je oko 37 % dobiti. Dividenda je rasla 9,7 % godišnje u poslednjih 19 godina. Medijana analitičke ciljane cene je 6.222,00 INR, odnosno iznad trenutnu cenu za 65,2 %. Od 8 analitičara 5 preporučuje kupovinu — ukupni konsenzus je Kupi.
Cena akcije Pfizer
Pristupite ovim podacima preko Eulerpool API-ja
100.000 zahteva/mes. besplatno · bez kartice
Pfizer poslovni model i analiza akcije
Često postavljana pitanja o akciji Pfizer
The business model of Pfizer Ltd revolves around pharmaceutical research, development, manufacturing, and sales. As a leading global biopharmaceutical company, Pfizer focuses on discovering breakthrough medicines and vaccines for various health conditions. With a diverse portfolio, Pfizer aims to improve patient lives and promote better health outcomes by investing in innovative research and development. Through strategic partnerships and collaborations, Pfizer strives to advance healthcare solutions while maintaining a strong commitment to delivering quality products. By upholding high standards of scientific integrity and ethical business practices, Pfizer continues to contribute to the well-being of individuals worldwide.
Pfizer Ltd is primarily active in the pharmaceutical industry. Its core business focuses on the research, development, manufacture, and sale of a wide range of pharmaceutical products. Pfizer Ltd is a renowned global pharmaceutical company, known for its breakthrough medicines and innovative therapies across various therapeutic areas. With a strong presence in the healthcare sector, Pfizer Ltd strives to enhance and improve the well-being of individuals worldwide.
The main competitors of Pfizer Ltd in the market include pharmaceutical companies such as Johnson & Johnson, Merck & Co., GlaxoSmithKline, and Novartis.
Pfizer Ltd. is a renowned pharmaceutical company with a rich history and background. Founded in 1849, Pfizer has evolved into a leading global player in the healthcare industry. With headquarters in the United States, the company has expanded its reach worldwide, including operations in India through Pfizer Ltd. Pfizer Ltd. is committed to discovering, developing, and manufacturing innovative medicines, vaccines, and consumer healthcare products. The company's relentless pursuit of medical advancements and dedication to improving people's lives has earned Pfizer Ltd. a strong reputation and recognition as a trusted name in the pharmaceutical sector.
Pfizer Ltd, a renowned pharmaceutical company, has achieved several significant milestones over the years. Notably, Pfizer is credited with the development of life-saving drugs like Viagra, Lipitor, and Zoloft, which have had a tremendous impact on global healthcare. Pfizer's contributions in the fields of immunology, oncology, and cardiology have not gone unnoticed, establishing the company as a leader in medical advancements. Pfizer's commitment to research and innovation has resulted in groundbreaking treatments, ensuring better clinical outcomes for patients worldwide. This dedication to excellence and their bold pursuit of scientific breakthroughs have made Pfizer Ltd a trusted and influential player in the pharmaceutical industry.
Pfizer Ltd, a leading pharmaceutical company, has a prominent presence in various countries and regions globally. The company operates in several key markets, including the United States, Europe, Asia-Pacific, Latin America, and Africa. With its headquarters in New York, Pfizer Ltd has established a strong foothold in the United States, utilizing its extensive network for research, development, and distribution of innovative healthcare solutions. Additionally, Pfizer Ltd's operations span across Europe, where it operates in numerous countries, catering to diverse healthcare needs. Further, the company's presence extends to the Asia-Pacific region, Latin America, and Africa, emphasizing its commitment to addressing global health challenges effectively.
Pfizer Ltd represents a set of core values and a strong corporate philosophy. As a renowned pharmaceutical company, Pfizer Ltd is committed to innovation and scientific advancement in the healthcare industry. The company believes in providing high-quality and safe medications to improve patient outcomes. Pfizer Ltd also emphasizes integrity, ethical practices, and transparency in all aspects of its operations. With a dedication to research and development, Pfizer Ltd aims to discover and deliver life-saving and life-enhancing therapies for people worldwide. This commitment, along with a customer-centric approach, makes Pfizer Ltd a trusted name in the pharmaceutical sector.
Analitičari trenutno postavljaju prosečnu ciljanu cenu 6.389,08 INR za akciju Pfizer (medijana: 6.222,00 INR), što znači +69,6 % u odnosu na poslednju cenu. Konsenzus se zasniva na 8 ocena.
9 analitičara trenutno ocenjuje akciju Pfizer: 6 preporučuje kupovinu, 3 držanje i 0 prodaju.
Po trenutnom kursu akcija Pfizer kotira 35,48 EUR (3.766,50 INR).
Akcija Pfizer (PFIZER.NS) kotira na 2 berze, uključujući: NSE (Indien) (PFIZER.NS).
Pfizer Ltd is a pharmaceutical company that focuses on the research, development, and marketing of products for the prevention and treatment of diseases. It has a global customer base and operates in various medical fields such as oncology, immunology, neurology, and infectious diseases. The company offers a wide range of medications, from well-established drugs to new therapies and biotechnological products. Its business model is centered on growth and profitability, with investments in research and development to remain competitive. Pfizer Ltd is organized into different divisions, including oncology, infectious diseases, immunology, and neurology, and also engages in the development of biotechnology products. Its products are marketed globally through pharmaceutical distribution channels. Overall, Pfizer Ltd strives to improve the health of patients worldwide through the development and marketing of innovative therapies.
prihod od Pfizer je 25,20 Млрд INR. Ova cifra je zasnovana na trenutnim finansijskim podacima i odražava poslovne rezultate preduzeća.
dobit od Pfizer je 7,22 Млрд INR. Neto dobit pokazuje profitabilnost preduzeća nakon odbitka svih troškova.
Odnos cene i zarade (KGV) za Pfizer je trenutno 23,85. KGV poredi sadašnju cenu akcije sa zaradom po akciji i pomaže investitorima da procene valuaciju akcije Pfizer.
Odnos cene i prihoda (KUV) za Pfizer je trenutno 6,84. KUV poredi tržišnu kapitalizaciju sa godišnjim prihodima i služi kao metrika valuacije za akciju Pfizer.
Eulpool score kvaliteta za Pfizer je 5/10.
ISIN za Pfizer je INE182A01018. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.
Ticker za Pfizer je PFIZER.NS. Simbol tikera se koristi za trgovinu akcijama Pfizer na berzanskom tržištu.
Pfizer акција
Pfizer Peer grupa
Pfizer Тикер
Pfizer FIGI
Sve ključne metrke i detaljne analize Pfizer u dubinskoj analizi
Naša analiza akcija za akciju Pfizer uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Pfizer. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: